ELMOD1
Basic information
Region (hg38): 11:107591091-107666779
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELMOD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 2 | 0 |
Variants in ELMOD1
This is a list of pathogenic ClinVar variants found in the ELMOD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-107630419-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
11-107630430-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
11-107630448-T-G | not specified | Uncertain significance (Apr 22, 2024) | ||
11-107630453-A-G | Likely benign (Feb 01, 2023) | |||
11-107630478-G-A | not specified | Uncertain significance (Nov 20, 2024) | ||
11-107630501-A-T | not specified | Uncertain significance (Mar 28, 2023) | ||
11-107630514-C-T | not specified | Uncertain significance (May 10, 2024) | ||
11-107630714-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
11-107631599-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
11-107631610-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
11-107631613-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
11-107631667-G-A | not specified | Likely benign (Jan 20, 2023) | ||
11-107635683-G-C | not specified | Uncertain significance (Feb 28, 2023) | ||
11-107635694-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
11-107650343-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
11-107650387-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
11-107650394-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
11-107654186-C-T | not specified | Uncertain significance (May 31, 2023) | ||
11-107655982-C-A | not specified | Uncertain significance (Oct 26, 2022) | ||
11-107656019-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
11-107665037-A-G | not specified | Uncertain significance (Nov 14, 2023) | ||
11-107665038-T-G | not specified | Uncertain significance (Oct 12, 2022) | ||
11-107665046-A-G | not specified | Uncertain significance (May 03, 2023) | ||
11-107665094-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
11-107665112-G-T | not specified | Uncertain significance (May 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ELMOD1 | protein_coding | protein_coding | ENST00000265840 | 11 | 75689 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.793 | 0.207 | 124593 | 0 | 4 | 124597 | 0.0000161 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.984 | 136 | 172 | 0.789 | 0.00000928 | 2198 |
Missense in Polyphen | 51 | 78.495 | 0.64972 | 957 | ||
Synonymous | 1.69 | 44 | 60.7 | 0.725 | 0.00000337 | 577 |
Loss of Function | 3.32 | 3 | 18.4 | 0.163 | 8.40e-7 | 248 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000647 | 0.0000646 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000182 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000183 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a GTPase-activating protein (GAP) toward guanine nucleotide exchange factors like ARL2, ARL3, ARF1 and ARF6, but not for GTPases outside the Arf family. {ECO:0000269|PubMed:17452337}.;
Recessive Scores
- pRec
- 0.0962
Intolerance Scores
- loftool
- 0.350
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.04
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- Y
- hipred_score
- 0.687
- ghis
- 0.607
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.807
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Elmod1
- Phenotype
- homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; immune system phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- positive regulation of GTPase activity
- Cellular component
- nucleoplasm;cytosol
- Molecular function
- GTPase activator activity